We are live on ! Find out more

Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
XBIO icon
526
Xenetic Biosciences
XBIO
$4.8M
$4.8M $2.05 3.3%
TRAW icon
527
Traws Pharma
TRAW
$4.55M
$4.55M $0.2960 1.66%
NCNA icon
528
NuCana
NCNA
$4.2M
$4.2M $1.01 2.88%
XTLB icon
529
XTL Biopharmaceuticals
XTLB
$3.96M
$3.96M $1.61 8.52%
DRMA icon
530
Dermata Therapeutics
DRMA
$3.84M
$3.84M $0.7750 7.86%
LIMN
531
Liminatus Pharma
LIMN
$3.79M
$3.79M $2.82 2.76%
NRSN icon
532
NeuroSense Therapeutics
NRSN
$3.77M
$3.77M $1.99 6.57%
JAGX icon
533
Jaguar Health
JAGX
$3.76M
$3.76M $1.62 20.6%
CVKD icon
534
Cadrenal Therapeutics
CVKD
$3.51M
$3.51M $0.9850 4.41%
GRI icon
535
GRI Bio
GRI
$3.34M
$3.34M $1.53 2.55%
EOCN icon
536
Eocene Ltd. Ordinary Shares
EOCN
$3.31M
$3.31M $3.10 3.73%
SXTP icon
537
60 Degrees Pharmaceuticals
SXTP
$3.31M
$3.31M $0.9400 0.79%
ONCO icon
538
Onconetix
ONCO
$3.3M
$3.3M $0.5610 4.27%
PMCB icon
539
PharmaCyte Biotech
PMCB
$3.24M
$3.24M $0.3021 9.03%
KALA icon
540
KALA BIO
KALA
$3.2M
$3.2M $0.1655 5.48%
CMND icon
541
Clearmind Medicine
CMND
$3.16M
$3.16M $6.22 6.32%
MBIO icon
542
Mustang Bio
MBIO
$3.03M
$3.03M $0.4001 1.94%
ENLV icon
543
Enlivex Ltd
ENLV
$2.73M
$2.73M $1.78 29.9%
SILO icon
544
Silo Pharma
SILO
$2.71M
$2.71M $1.23 1.6%
JUNS
545
Jupiter Neurosciences
JUNS
$2.7M
$2.7M $2.05 13.5%
HCWB icon
546
HCW Biologics
HCWB
$2.46M
$2.46M $1.10 6.78%
APVO icon
547
Aptevo Therapeutics
APVO
$2.43M
$2.43M $1.34 1.47%
ERNA icon
548
Eterna Therapeutics
ERNA
$2.3M
$2.3M $1.97 6.64%
REVB icon
549
Revelation Biosciences
REVB
$2.29M
$2.29M $4.03 7.47%
ELAB icon
550
Elevai Labs
ELAB
$2.1M
$2.1M $2.60 1.52%
19 20 21
22
23

Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 570 Biotechnology industry stocks tracked by Wall St. Rank, worth a combined $1.31T.

The largest by market cap are Vertex Pharmaceuticals (VRTX) at $142B, Regeneron Pharmaceuticals (REGN) at $96B and Moderna (MRNA) at $88.5B.

Among institutional investors, Revolution Medicines (RVMD) drew the most net new fund positions in Q2 2026: 246 funds opened new positions, taking total fund holders up 181 (35%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.